Quickest Way to Move a Key Element of the RFK, Jr. Agenda

The past month has been a series of whining tomes from the dying voices of legacy media about how the MAGA Agenda demanded by the American people can be blocked ,or hobbled or diverted.  No stone has been left unturned; or un-thrown.  From the deluded rant from mandarins of the elite, Evan Davis was editor in chief of the Columbia Law Review and David Schulte was editor in chief of the Yale Law Journal, to countless checklists of how to prevent any of the reforms embraced by the Trump team, the establishment is in a tail-spin of fruitless schemes and crazed plots.

            A somewhat more rational piece was recently published by the New York Times detailing all the hurdles Robert F. Kennedy, Jr. would face in his oft stated goal of ending Big Pharma’s funneling of billions of dollars in so-called “advertising” to the corporate media conglomerates.  The article by Rebecca Robbins lists all of the reasons why Kennedy is likely to fail.

            Big Pharma will claim their First Amendment rights are being violated should Kennedy move to end the more than $5 billion a year that is directed to the legacy media.  Hacks-in-black – a.k.a. politicized federal judges – have gone so far to prevent even slight mandates to such advertising.  In the first Trump administration an effort to require the drug companies to state the price of a drug in the ad was overturned.

            With much of the MAGA movement focused on destroying the censorship industry that has been built to attack any views not approved by the globalist regime, the First Amendment claim of Big Pharma will have more resonance than normal.

            But there is no need for an outright ban on pharmaceutical ads.  The same thing can be accomplished by relying on a time-tested approach.  Like the government did to bring down thugs across America, most notably Al Capone, we should look to the IRS for help in solving this problem.  The approach is very simple.

            The IRS has the power to determine what is and what is not a deductible expense by business.  They change these rules all the time.  There is an entire industry of lawyers and lobbyists who do nothing but play this game with the bureaucrats.  So, what if the new IRS Commissioner determined that money spent by the drug companies for advertising on legacy media was not a legitimate business expense and denied them the ability to deduct the expense on their taxes?  That would put another $5 billion on the taxable side of things. 

            Would it eliminate drug company subsidy of legacy media?  No, probably not.  But it would draw some fiscal blood from them.  And, it would add to government revenue that might go toward reducing the insane deficit.  All in all, not a bad day’s work and a start at starving the propaganda machine and holding the purveyors of poison to account.